Comparative effectiveness research in follicular lymphoma: current and future perspectives and challenges

Journal of Comparative Effectiveness Research
Kitsada Wudhikarn, Brian K Link

Abstract

Follicular lymphoma (FL) is the most common indolent non-Hodgkin's lymphoma in northern America. FL is an incurable disease with relapsing-remitting courses requiring serial intermittent treatments. Duration of remission will often become progressively shorter and most patients will die from refractory disease or transformation to aggressive lymphoma. Given the incurable nature of FL, current goals of treatment are focused on improving symptoms and survival by a variety of available treatment options, while considering potential adverse events. Although randomized controlled trials are universally perceived as the gold standard of clinical research, randomized controlled trials are not always practical and have several limitations. Therapeutic and diagnostic options of FLs are expanding faster than randomized controlled trials can test them, so employing comparative effectiveness research on other research designs are needed to efficiently improve global FL care. Implementing comparative effectiveness research with judicious use of appropriate research designs will hopefully fill current knowledge gaps and provide insights for FL managements.

References

Jun 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A Z RohatinerJ Matthews
Sep 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wen-Kai Weng, Ronald Levy
May 26, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pier Luigi ZinzaniMichele Baccarani
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Heiko SchöderHenry W D Yeung
Sep 10, 2005·Blood·Lindsay M MortonMartha S Linet
Aug 22, 2007·Blood·Pamela SeamBruce D Cheson
Jul 30, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert MarcusGeorge Stein
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jonathan W FriedbergBrian K Link
Jul 2, 2009·Annals of Internal Medicine·Harold C Sox, Sheldon Greenfield
Jul 2, 2009·The New England Journal of Medicine·John K Iglehart
Aug 5, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Massimo FedericoPhilippe Solal-Céligny
May 5, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marinus H J van OersAnton Hagenbeek
Jun 3, 2010·JAMA : the Journal of the American Medical Association·Michael S Lauer, Francis S Collins
Jun 12, 2010·Leukemia & Lymphoma·Annarita ConconiEmanuele Zucca
Jul 10, 2010·Blood·Chris Pepper
Jun 11, 2011·Best Practice & Research. Clinical Haematology·E LeichA Rosenwald
Jul 9, 2011·Blood·James Olen Armitage
Aug 4, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nathan FowlerBruce D Cheson
Nov 26, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Eitan AmirAlberto Ocaña
Dec 23, 2011·Journal of the National Cancer Institute·Murtadha Al KhaboriMichael Crump
Jan 4, 2012·British Journal of Haematology·Christopher McNamaraUNKNOWN British Society for Haematology Committee
Mar 17, 2012·Blood·Andrea Velardi
Jun 1, 2012·Blood·Claire Dearden
Jun 2, 2012·Blood·Rüdiger Hehlmann
Jun 22, 2012·American Journal of Hematology·Bridget CharbonneauJames R Cerhan
Aug 18, 2012·Journal of Oncology·C Bodet-MilinF Kraeber-Bodéré
Aug 24, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jonathan W FriedbergThomas P Miller

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
PCR

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Blood Reviews
Maher K Gandhi, Robert E Marcus
Critical Care Nursing Quarterly
Prakash L Mokshagundam
Cancer Control : Journal of the Moffitt Cancer Center
Celeste BelloMojdeh Naghashpour
Circulation Journal : Official Journal of the Japanese Circulation Society
Sumio YamadaPTMaTCH collaborators
© 2021 Meta ULC. All rights reserved